November 11 RxAdvocate November, 2023 — Newsletter
FDA Approves Drug for Postpartum Depression National Diabetes Month New Weight Loss Drug, Zepbound Community Involvement...
Author: FTHD
November 11 FDA Approves New Weight Loss Drug, Zepbound
FDA Approves New Weight Loss Drug, Zepbound...
November 11 RxAdvocate October, 2023 — Newsletter
2 Biosimilars Hitting the Market RSV Season GLP-1 Studies to Improve Alzheimer's Community Involvement...
November 11 RxAdvocate September, 2023 — Newsletter
FDA Approves Vyvanse Generics BCBS/California Drops CVS FDA Approves ABRYSVO Community Involvement...
September 9 Flipping the Script: 5 Key Insights About Blue Shield’s Pharma Industry Shakeup
5 Key Insights About Blue Shield's Pharma Industry Shakeup...
August 8 RxAdvocate August, 2023 — Newsletter
DTC Drug Marketing GLP-1 Drugs/Stomach Paralysis Adderall Shortage Community Involvement...
August 8 RxAdvocate July, 2023 — Newsletter
Gene Therapy for Hemophilia A UV Safety Gene Therapy for Muscular Dystrophy Employee Highlights...
June 6 RxAdvocate June, 2023 — Newsletter
FDA approves Rinvoq for Crohn's Disease Humira Biosimilars Congenital Heart Disease Community Involvement ...
May 5 RxAdvocate May, 2023 — Newsletter
FDA Update: Opioids Advertising on Weight Loss Medication OTC Hearing Aids ...
April 4 RxAdvocate April, 2023 — Newsletter
COVID Update Drug Shortages OTC Narcan Announcements...